Pathogenic potential of galactose‐deficient IgA1 in IgA nephropathy
- 1 June 2002
- journal article
- Published by Wiley in Nephrology
- Vol. 7 (s3) , S92-S99
- https://doi.org/10.1046/j.1440-1797.7.s3.3.x
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Differential immune responses to α-gal epitopes on xenografts and allografts: implications for accommodation in xenotransplantationJournal of Clinical Investigation, 2000
- Study of the Relationship between Sticky Human Serum IgA1 and Its O-Glycan GlycoformBiochemical and Biophysical Research Communications, 1999
- Structural heterogeneity of glycans in IgA molecules: Implications for IgA nephropathyNephrology, 1997
- Interaction of the natural anti-Gal antibody with α-galactosyl epitopes: a major obstacle for xenotransplantation in humansImmunology Today, 1993
- Persistent repression of a functional allele can be responsible for galactosyltransferase deficiency in Tn syndrome.Journal of Clinical Investigation, 1993
- Interactions of galactosyltransferase with serum and secretory immunoglobulins and their component chainsMolecular Immunology, 1993
- T cell clones with normal or defective O‐galactosylation from a patient with permanent mixed‐field polyagglutinabilityEuropean Journal of Immunology, 1992
- Complement‐Fixing Properties of Human IgA Antibodies Alternative Pathway Complement Activation by Plastic‐Bound, But Not Specific Antigen‐Bound, IgAScandinavian Journal of Immunology, 1989
- Aberrant synthesis of antibodies directed at the Fab fragment of IgA in patients with IgA nephropathiesClinical Immunology and Immunopathology, 1987
- Carbohydrate-mediated clearance of secretory IgA from the circulationMolecular Immunology, 1985